Biological Effects of Novel Synthetic Guanidine Derivatives Targeting Leishmania (Viannia) braziliensis
Authors:
- Geovane Dias-LopesGDGeovane Dias-Lopes
- Luana Ribeiro Dos AnjosLALuana Ribeiro Dos Anjos
- Sara Maria Xavier da CruzSCSara Maria Xavier da Cruz
- Cauã Dias AbrãoCACauã Dias Abrão
- Maria Eduarda Pinto GonçalvesMGMaria Eduarda Pinto Gonçalves
- Franklin Souza-SilvaFSFranklin Souza-Silva
- Anna FabisikovaAFAnna Fabisikova
- Eduardo Rene Perez GonzálezEGEduardo Rene Perez González
- Carlos Roberto AlvesCarlos Roberto Alves
Open Access
Abstract
Leishmaniasis remains an important neglected tropical disease, and current treatments are limited by toxicity, resistance, and low bioavailability. In this study, novel guanidine derivatives were evaluated through an integrated approach, combining in silico physicochemical profiling with in vitro biological assays using Leishmania (Viannia) braziliensis, the etiological agent of American Tegumentary Leishmaniasis (ATL). Most compounds exhibited favorable drug-like properties, though variations in lipophilicity and solubility influenced biological performance. Among the tested molecules, FURL-G5 emerged as the most promising candidate, showing potent activity against promastigote forms and low cytotoxicity in murine macrophages, resulting in high selectivity indices (SI > 10), comparable to those of LQOF-G1, a compound with previously established leishmanicidal effects. These compounds were also tested on intracellular amastigotes, drastically reducing the infection rate of macrophages. The integration of an in silico approach and biological validation enabled rational compound prioritization and supports the early-stage development of these scaffolds. Overall, this study reinforces the potential of guanidine-based compounds as leads for innovative ATL drug discovery and demonstrates the value of multidisciplinary strategies for identifying selective and safe therapeutic candidates.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (305287/2023-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (441634/2024-9)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—Brazil (E-26/010.000983/2019)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—Brazil (E-26/203.931/2024)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—Brazil (E-26/210.712/2025)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/02595-8)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2025/01056-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 49 references indexed in Scilit:
- Oral bioavailability property prediction based on task similarity transfer learningMolecular Diversity, 2025
- Exploring Lamiaceae diterpenoids as potential multitarget therapeutics for leishmaniasis and chagas diseaseMolecular Diversity, 2025
- Antifungal activity of guanidine compoundsBrazilian Journal of Microbiology, 2025
- Guanidine dicycloamine-based analogs: green chemistry synthesis, biological investigation, and molecular docking studies as promising antibacterial and antiglycation leadsMolecular Diversity, 2024
- Axenic amastigotes of Leishmania species as a suitable model for in vitro studiesActa Tropica, 2021
- Synthesis and algicidal activity of new dichlorobenzylamine derivatives against harmful red tidesBiotechnology and Bioprocess Engineering, 2016
- Fluorine in Medicinal Chemistry2015
- Molecular mechanism of action of metformin: old or new insights?Diabetologia, 2013
- Leishmania antimony resistance: what we know what we can learn from the fieldParasitology Research, 2011
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New WorldActa Tropica, 2011